UBS Group AG current report, Q4 FY2016

Full document

UBS Group AG: Basel III Pillar 3 Report Summary (Year Ended Dec 31, 2016)

Business Context and Reporting Period

This Form 6-K filing, dated March 10, 2017, contains the Basel III Pillar 3 disclosures for UBS Group AG for the period ended December 31, 2016. The report details regulatory capital, risk-weighted assets (RWA), leverage, liquidity, and remuneration in accordance with the Swiss Financial Market Supervisory Authority (FINMA) and Basel Committee on Banking Supervision (BCBS) frameworks. UBS is classified as a Systemically Relevant Bank (SRB) under Swiss law and a Global Systemically Important Bank (G-SIB).

Key Financial Metrics

Capital and Risk-Weighted Assets (RWA)

  • Total RWA: CHF 225.4 billion (Phase-in basis).
  • Common Equity Tier 1 (CET1) Capital: CHF 37.8 billion (Ratio: 16.8%).
  • Total Capital: CHF 56.5 billion (Ratio: 25.0%).
  • Minimum Capital Requirement: CHF 18.0 billion (8% of RWA).

Leverage Ratio

  • Phase-in Basis: 5.1% (Tier 1 Capital: CHF 44.9 billion; Denominator: CHF 874.9 billion).
  • Fully Applied Basis: 4.6% (Tier 1 Capital: CHF 39.8 billion; Denominator: CHF 870.5 billion).

Liquidity

  • Liquidity Coverage Ratio (LCR): 132% (Average for Q4 2016), exceeding the 110% minimum requirement.
  • High-Quality Liquid Assets (HQLA): CHF 196 billion.
  • Net Cash Outflows: CHF 148 billion.

Exposure Breakdown (RWA)

  • Credit Risk: CHF 84.9 billion (excluding counterparty credit risk).
  • Counterparty Credit Risk (CCR): CHF 29.4 billion.
  • Market Risk: CHF 15.5 billion.
  • Operational Risk: CHF 77.8 billion.

Material Changes and Regulatory Developments

The report reflects the first-time application of revised Pillar 3 disclosure requirements effective December 31, 2016. Key changes include:

  • Asset Classification: Shift from BIS-defined exposure segments to FINMA-defined asset classes.
  • Counterparty Credit Risk (CCR): CCR is now separately disclosed from credit risk, including OTC derivatives, exchange-traded derivatives, and securities financing transactions.
  • Linkage to Financial Statements: New tables introduced to map IFRS carrying values to regulatory risk categories.
  • LCR Improvement: The LCR increased by 8 percentage points in Q4 2016 compared to Q3, driven by a reduction in net cash outflows from securities financing transactions.

Outlook, Risks, and Management Commentary

Market Risk and VaR: Regulatory Value-at-Risk (VaR) and Stressed VaR (SVaR) increased in the second half of 2016 due to market volatility (China, emerging markets, UK referendum) but returned to lower levels by year-end. There were seven regulatory VaR backtesting exceptions in 2016, leading to an increase in the FINMA VaR multiplier to 3.65.

Credit Risk: Total impaired financial instruments stood at CHF 1.2 billion. The bank utilizes the Advanced Internal Ratings-Based (A-IRB) approach for the majority of its credit portfolio. Management notes that the A-IRB approach better captures economic risk compared to the Standardized Approach (SA), particularly for low-risk portfolios.

Interest Rate Risk: The economic value effect of a +/- 200 basis point parallel shift in interest rates remains significantly below the 20% of eligible capital threshold. Sensitivity to rising rates decreased to negative CHF 3.1 million per basis point.

G-SIB Status: The Financial Stability Board (FSB) determined UBS's G-SIB capital buffer requirement to be 1.0% based on 2015 indicators. UBS states its Swiss SRB requirements exceed these BCBS requirements.

Investor Verification Checklist

  • Capital Adequacy: Verify the CET1 ratio of 16.8% against the required minimum of 5.6% (including buffers) to confirm the capital buffer.
  • Liquidity Position: Confirm the LCR of 132% remains sustainable given the reduction in net cash outflows.
  • RWA Composition: Review the high proportion of Operational Risk RWA (CHF 77.8 billion) relative to Credit and Market Risk.
  • Backtesting Exceptions: Assess the impact of the seven VaR backtesting exceptions on the capital multiplier and future capital requirements.
  • Subsidiary Metrics: Review the standalone capital ratios for significant subsidiaries (UBS AG, UBS Limited, UBS Americas Holding LLC) provided in Section 16.